Home
>
National Drug Code (NDC)
>
Campath
Campath - 58468-0357-1 - (ALEMTUZUMAB)
Drug Information of Campath
| Product NDC: | 58468-0357 |
| Proprietary Name: | Campath |
| Non Proprietary Name: | ALEMTUZUMAB |
| Active Ingredient(s): | 30 mg/mL & nbsp; ALEMTUZUMAB |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Campath
| Product NDC: | 58468-0357 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103948 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20091130 |
Package Information of Campath
| Package NDC: | 58468-0357-1 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (58468-0357-1) > 1 mL in 1 VIAL, SINGLE-USE |
NDC Information of Campath
| NDC Code | 58468-0357-1 |
| Proprietary Name | Campath |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (58468-0357-1) > 1 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 58468-0357 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ALEMTUZUMAB |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091130 |
| Marketing Category Name | BLA |
| Labeler Name | Genzyme Corporation |
| Substance Name | ALEMTUZUMAB |
| Strength Number | 30 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | CD52-directed Antibody Interactions [MoA],CD52-directed Cytolytic Antibody [EPC] |
